Effect of vitamin E and beta carotene on the incidence of angina pectoris: A randomized, double-blind, controlled trial

JAMA

Volumn 275, Issue 9, 1996, Pages 693-698

  Rapola, Janne M ^a   Virtamo, Jarmo ^a   Haukka, Jari K ^a   Heinonen, Olli P ^a   Albanes, Demetrius ^b   Taylor, Philip R ^b   Huttunen, Jussi K ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; VITAMIN INTAKE;

EID: 0030033916     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.9.693     Document Type: Article

References (47)

1. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991;32:1325-1332.
2. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by β-carotene, Arterioscler Thromb. 1993; 13:590-600.
3. Jialal I, Grundy SM. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotem oxidation. Circulation. 1993;88:2780-2786.
4. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation: a dose response study. Arterioscler Thromb Vasc Biol. 1995;15:190-198.
5. Princen HMG, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol. 1995;15:325-333.
6. Jialal I, Norkus EP, Cristol L, Grundy SM. β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1991;1086:134-138.
7. Gaziano JM, Hennekens CH. The role of beta-carotene in the prevention of cardiovascular disease Ann N Y Acad Sci. 1993;691:148-155.
8. Gaziano JM, Hatta A, Flynn M, et al. Supplementation with β-carotene in vivo and in vitro does not inhibit low density-lipoprotein oxidation. Atherosclerosis. 1995;112:187-195.
9. Reaven PD, Ferguson E, Navab M, Powell FL. Susceptibility of human LDL to oxidative modification: effects of variations in β-carotene concentration and oxygen tension. Arteriascler Thromb. 1994;14:1162-1169.
10. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr, 1991;10:466-473.
11. Chatelain E, Boscoboinik DO, Bartoli GM, et al. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta. 1993;1176:83-89.
12. Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL. Inhibition of IL-1beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis. 1991;86:261-270.
13. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
14. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
15. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180-1189.
16. Bellizzi MC, Franklin MF, Duthie GG, James WPT. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 1994;48:822-831.
17. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.
18. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J Clin Nutr. 1993;57(suppl):787S-797S.
19. Street DA, Comstock GW, Salkeld RM, Schüep W, Klag MJ. Serum antioxidants and myocardial infarction: are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation. 1994;90:1154-1161.
20. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial and follow-up study. JAMA. 1994;272:1439-1441.
21. Kardinaal AFM, Kok FJ, Ringstad J, et al Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet. 1993;342: 1379-1384.
22. Gaziano JM, Manson J, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina. Circulation. 1990;82(suppl III):III-201. Abstract.
23. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
24. The ATBC Cancer Prevention Study Group. The Alpha-Toeopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1994;4:1-10.
25. Pietinen P, Hartman AM, Haapa E, et al. Reproducibility and validity of dietary assessment instruments, I: a self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-666.
26. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys Bull World Health Organ. 1962;27:645-658.
27. Milne DB, Botnen J. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem. 1986;32:874-876.
28. Kattermann R, Jaworek D, Möller G. Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem. 1984;22-245-251.
29. Kostner GM. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem. 1976; 22:695.
30. Rose GA. Chest pain questionnaire. Milbank Mem Fund Q. 1965;43:32-39.
31. Heyden S, Bartel AG, Tabesh E, et al. Angina pectoris and the Rose questionnaire. Arch Intern Med. 1971;128:961-964.
32. Reunanen A. Prevalence and Prognosis of Chest Pains Suggesting Coronary Heart Disease in Middle Aged Men and Women. Helsinki: Social Insurance Institution Finland; 1977;8. (Written in Finnish with a summary in English.)
33. Erikssen J, Enge I, Forfang K, Storstein O. False positive diagnostic tests and coronary angiographic fingings in 105 presumably healthy males. Circulation. 1976;54:371-376.
34. Garber CE, Carleton RA, Heller GV. Comparison of 'Rose questionnaire angina' to exercise thallium scintigraphy: different findings in males and females. J Clin Epidemiol. 1992;45:715-720.
35. Rose G. Predicting coronary heart disease from minor symptoms and electrocardiographic findings. Br J Prev Soc Med. 1971;25:94-96.
36. Rose G, Reid DD, Hamilton PJS, McCartney P, Keen H, Jarrett RJ. Myocardial ischaemia, risk factors and death from coronary heart disease. Lancet. 1977;1:105-109.
37. Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P. The Social Insurance Institution's Coronary Heart Disease Study: Baseline Data and 5-Year Mortality Experience. Helsinki: Social Insurance Institution Finland; 1983.
38. Rose G. Variability of angina: some implications for epidemiology. Br J Prev Soc Med. 1968; 22:12-15.
39. Zeiner-Henriksen T. The repeatability at interview of symptoms of angina and possible infarction. J Chronic Dis. 1972;25:407-414.
40. Cook DG, Shaper AG, Macfarlane PW. Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology, Int J Epidemiol. 1989;18: 607-613.
41. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley & Sons; 1973:130-154.
42. Princen HMG, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vase Biol. 1995;15:325-333.
43. National Research Council Subcommittee on the Tenth Edition of the RDAs. Recommended Dietary Allowances. 10th ed. Washington, DC: National Academy Press; 1989.
44. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991;53(suppl):326S-334S.
45. Hense HW, Stender M, Bors W, Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis. 1993;103:21-28.
46. Anderson TW. Vitamin E in angina pectoris. Can Med Assoc J. 1974;110:401-406.
47. Gillilan RE, Mondell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J. 1977;93:444-449.